Clinical Trial Update: Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic Shock [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on hemoperfusion with a polymyxin B-immobilized membrane for peritonitis with septic shock; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritonitis
• Septic Shock

Drugs mentioned

• Polymyxin B-immobilized hemoperfusion cartridge (polymyxin B-immobilized hemoperfusion cartridge)

Snippet

Sponsor: Meditor SAS | Conditions: Peritonitis, Septic Shock | Phase 3 | Status: COMPLETED